Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Get started Well-being and workplace resources Through our well-being and workplace initiatives, APhA offers tools to help pharmacy personnel thrive in healthier and more sustainable ways
Per-Compound Adverse Events Retatrutide The Jastreboff 2023 Phase 2 trial (Jastreboff et al., 2023) and the TRIUMPH-4 Phase 3 trial (Bays et al., 2025) anchor retatrutide's safety profile
Written by Elizabeth Tito, BSc Genetics, MPH Elizabeth is a science and medical writer with a background in Genetics and Public Health
This lot's tested vial: 10 mg
They bind to receptors on cells and trigger a range of biological effects, from the regeneration of tissue to the production of hormones making them an increasingly important class of drugs
